FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311236615> ?p ?o ?g. }

• W4311236615 endingPage "6137" @default.
• W4311236615 startingPage "6137" @default.
• W4311236615 abstract "Current chemoradiation therapy suffers from normal tissue toxicity. Thus, we are proposing incorporating gold nanoparticles (GNPs) and docetaxel (DTX), as they have shown very promising synergetic radiosensitization effects. Here, we explored the effect of a DTX prodrug encapsulated in lipid nanoparticles (LNPDTX-P) on GNP uptake in pancreatic cancer models in vitro and in vivo. For the in vitro experiment, a pancreatic cancer cell line, MIA PaCa-2, was cultured and dosed with 1 nM GNPs and 45 nM free DTX or an equivalent dose of LNPDTX-P. For the in vivo experiment, MIA PaCa-2 cells were implanted subcutaneously in NRG mice, and the mice were dosed with 2 mg/kg of GNPs and 6 mg/kg of DTX or an equivalent dose of LNPDTX-P. The results show that LNPDTX-P-treated tumour samples had double the amount GNPs compared to control samples, both in vitro and in vivo. The results are very promising, as LNPDTX-P have superior targeting of tumour tissues compared to free DTX due to their nanosize and their ability to be functionalized. Because of their minimal toxicity to normal tissues, both GNPs and LNPDTX-P could be ideal radiosensitization candidates in radiotherapy and would produce very promising synergistic therapeutic outcomes." @default.
• W4311236615 created "2022-12-24" @default.
• W4311236615 creator A5000724233 @default.
• W4311236615 creator A5000937284 @default.
• W4311236615 creator A5009731325 @default.
• W4311236615 creator A5018164654 @default.
• W4311236615 creator A5026913056 @default.
• W4311236615 creator A5031036541 @default.
• W4311236615 creator A5041874144 @default.
• W4311236615 creator A5049380011 @default.
• W4311236615 creator A5071405218 @default.
• W4311236615 creator A5074855042 @default.
• W4311236615 date "2022-12-13" @default.
• W4311236615 modified "2023-09-30" @default.
• W4311236615 title "Lipid-Nanoparticle-Mediated Delivery of Docetaxel Prodrug for Exploiting Full Potential of Gold Nanoparticles in the Treatment of Pancreatic Cancer" @default.
• W4311236615 cites W1186528251 @default.
• W4311236615 cites W1838570471 @default.
• W4311236615 cites W1905903151 @default.
• W4311236615 cites W1984109928 @default.
• W4311236615 cites W1989230986 @default.
• W4311236615 cites W1992560340 @default.
• W4311236615 cites W1993345924 @default.
• W4311236615 cites W2009486292 @default.
• W4311236615 cites W2013262011 @default.
• W4311236615 cites W2024542128 @default.
• W4311236615 cites W2053441642 @default.
• W4311236615 cites W2055423604 @default.
• W4311236615 cites W2060366362 @default.
• W4311236615 cites W2066467291 @default.
• W4311236615 cites W2083361390 @default.
• W4311236615 cites W2129685713 @default.
• W4311236615 cites W2140808108 @default.
• W4311236615 cites W2141115871 @default.
• W4311236615 cites W2162546286 @default.
• W4311236615 cites W2188560360 @default.
• W4311236615 cites W2236922483 @default.
• W4311236615 cites W2413499751 @default.
• W4311236615 cites W26366664 @default.
• W4311236615 cites W2659186398 @default.
• W4311236615 cites W2736306093 @default.
• W4311236615 cites W2753110021 @default.
• W4311236615 cites W2778592108 @default.
• W4311236615 cites W2793070143 @default.
• W4311236615 cites W2796781998 @default.
• W4311236615 cites W2807410315 @default.
• W4311236615 cites W2913487062 @default.
• W4311236615 cites W2955295727 @default.
• W4311236615 cites W2968934833 @default.
• W4311236615 cites W2973014626 @default.
• W4311236615 cites W2976760128 @default.
• W4311236615 cites W2984284890 @default.
• W4311236615 cites W2990784324 @default.
• W4311236615 cites W2992823069 @default.
• W4311236615 cites W3005976323 @default.
• W4311236615 cites W3026855035 @default.
• W4311236615 cites W3035687571 @default.
• W4311236615 cites W3041520066 @default.
• W4311236615 cites W3096550744 @default.
• W4311236615 cites W3099846680 @default.
• W4311236615 cites W3128936751 @default.
• W4311236615 cites W3164967630 @default.
• W4311236615 cites W3173223047 @default.
• W4311236615 cites W3189762741 @default.
• W4311236615 cites W4289912270 @default.
• W4311236615 doi "https://doi.org/10.3390/cancers14246137" @default.
• W4311236615 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36551622" @default.
• W4311236615 hasPublicationYear "2022" @default.
• W4311236615 type Work @default.
• W4311236615 citedByCount "3" @default.
• W4311236615 countsByYear W43112366152023 @default.
• W4311236615 crossrefType "journal-article" @default.
• W4311236615 hasAuthorship W4311236615A5000724233 @default.
• W4311236615 hasAuthorship W4311236615A5000937284 @default.
• W4311236615 hasAuthorship W4311236615A5009731325 @default.
• W4311236615 hasAuthorship W4311236615A5018164654 @default.
• W4311236615 hasAuthorship W4311236615A5026913056 @default.
• W4311236615 hasAuthorship W4311236615A5031036541 @default.
• W4311236615 hasAuthorship W4311236615A5041874144 @default.
• W4311236615 hasAuthorship W4311236615A5049380011 @default.
• W4311236615 hasAuthorship W4311236615A5071405218 @default.
• W4311236615 hasAuthorship W4311236615A5074855042 @default.
• W4311236615 hasBestOaLocation W43112366151 @default.
• W4311236615 hasConcept C104819515 @default.
• W4311236615 hasConcept C108215921 @default.
• W4311236615 hasConcept C121608353 @default.
• W4311236615 hasConcept C126322002 @default.
• W4311236615 hasConcept C150903083 @default.
• W4311236615 hasConcept C155672457 @default.
• W4311236615 hasConcept C171250308 @default.
• W4311236615 hasConcept C178790620 @default.
• W4311236615 hasConcept C185592680 @default.
• W4311236615 hasConcept C192562407 @default.
• W4311236615 hasConcept C202751555 @default.
• W4311236615 hasConcept C207001950 @default.
• W4311236615 hasConcept C2780210213 @default.
• W4311236615 hasConcept C2781190966 @default.
• W4311236615 hasConcept C29730261 @default.
• W4311236615 hasConcept C502942594 @default.

• next